78370 Federal Register / Vol. 88, No. 219 / Wednesday, November 15, 2023 / Notices 

provision of, IL services. The Designated 

State Entity (DSE) is the agency that, on 

behalf of the state, receives, accounts 

for, and disburses funds received under 

Part B of the Rehabilitation Act of 1973, 

as amended (the Act). Funds are also 

made available for the provision of 

training and technical assistance to 

Statewide Independent Living Councils 

(SILCs). The Rehabilitation Act of 1973, 

as amended, requires three IL program 

reports: (1) State Plan for Independent 

Living (SPIL); (2) ILS Program 

Performance Report; and (3) Center for 

Independent Living (CIL) Program 

Performance Report. 

This request is for the ILS PPR, which 

is submitted annually by the SILC and 

DSE in every state, territory, and 

outlying area that receives Part B funds 

and in the District of Columbia. 

The ILS PPRs are used by ACL to 

assess grantees’ compliance with title 

VII of the Act, with 45 CFR part 1329 

of the Code of Federal Regulations, and 

with applicable provisions of the HHS 

Regulations at 45 CFR part 75. The ILS 

PPR serves as the primary basis for 

ACL’s monitoring activities in 

fulfillment of its responsibilities under 

sections 706 and 722 of the Act. The 

PPR is also used by ACL to design CIL 

and SILC training and technical 

assistance programs authorized by 

section 721 of the Act. 

ACL will adhere to best practices for 

collection of all demographic 

information in accordance with OMB 

guidance—including, but not limited to 

guidance specific to the collection of 

sexual orientation and gender identity 

(SOGI) items that support alignment 

with Executive Order 13985 on 

Advancing Racial Equity and Support 

for Underserved Communities Through 

the Federal Government, Executive 

Order 14075 on Advancing Equality for 

Lesbian, Gay, Bisexual, Transgender, 

Queer, and Intersex Individuals, and 

Executive Order 13988 on Preventing 

and Combating Discrimination on the 

Basis of Gender Identity and Sexual 

Orientation. Understanding these 

disparities can and should lead to 

improved service delivery for ACL’s 

programs and populations. 

The proposed data collection tools 

may be found on the ACL website for 

review at: https://www.acl.gov/aboutacl/public-input. 

Estimated Program Burden: ACL 

estimates the burden of this collection 

of information as follows: 

The PPR Instrument and Instructions 

will be sent to representatives of fifty 

states, the District of Columbia, Puerto 

Rico, American Samoa, the 

Commonwealth of the Northern Mariana 

Islands, Guam, and US Virgin Islands. 

The approximate burden for completion 

will be thirty-six hours per respondent, 

which includes time to review the 

instructions, read the questions, and 

complete responses. This results in a 

total survey burden estimate of 2,016 

hours. 

Respondent/data collection activity Number of 

respondents 

Responses 

per 

respondent 

Hours 

per response 

Annual 

burden hours 

Survey .............................................................................................................. 56 1 36 2016 

Dated: November 8, 2023. 

Alison Barkoff, 

Principal Deputy Administrator for the 

Administration for Community Living, 

performing the duties of the Administrator 

and the Assistant Secretary for Aging. 

[FR Doc. 2023–25133 Filed 11–14–23; 8:45 am] 

BILLING CODE 4154–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Community Living 

Agency Information Collection 

Activities: Proposed Collection; Public 

Comment Request; of the ACL Generic 

Clearance for the Collection of Routine 

Customer Feedback OMB 0985–NEW 

AGENCY: Administration for Community 

Living, Department of Health and 

Human Services. 

ACTION: Notice. 

SUMMARY: The Administration for 

Community Living (ACL) is announcing 

an opportunity for the public to 

comment on the proposed collection of 

information listed above. Under the 

Paperwork Reduction Act of 1995 

(PRA), Federal agencies are required to 

publish a notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension of an existing collection of 

information, and to allow 60 days for 

public comment in response to the 

notice. This Information Collection (IC) 

solicits comments on the IC 

requirements relating to the ACL 

Generic Clearance for the Collection of 

Routine Customer Feedback, a generic 

mechanism for Collecting Service 

Delivery Feedback under the Paperwork 

Reduction Act. 

DATES: Comments on the collection of 

information must be submitted 

electronically by 11:59 p.m. (EST) or 

postmarked by January 16, 2024. 

ADDRESSES: Submit electronic 

comments on the collection of 

information to: ACL’s Center for 

Management and Budget 

Tomakie.Washington@acl.hhs.gov. 

Submit written comments on the 

collection of information to 

Administration for Community Living, 

330 C Street SW, Washington, DC, 

20201, Attention: Center for 

Management and Budget PRA 

Comments. 

FOR FURTHER INFORMATION CONTACT: 

Tomakie Washington at 202–795–7336 

or Tomakie.Washington@acl.hhs.gov. 

SUPPLEMENTARY INFORMATION: Under the 

PRA, Federal agencies must obtain 

approval from the Office of Management 

and Budget (OMB) for each collection of 

information they conduct or sponsor. 

‘‘Collection of information’’ is defined 

as and includes agency requests or 

requirements that members of the public 

submit reports, keep records, or provide 

information to a third party. The PRA 

requires Federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension of an existing collection of 

information, before submitting the 

collection to OMB for approval. To 

comply with this requirement, ACL is 

publishing a notice of the proposed 

collection of information set forth in 

this document. 

With respect to the following 

collection of information, ACL invites 

comments on our burden estimates or 

any other aspect of this collection of 

information, including: 

(1) whether the proposed collection of 

information is necessary for the proper 

performance of ACL’s functions, 

including whether the information will 

have practical utility; 

(2) the accuracy of ACL’s estimate of 

the burden of the proposed collection of 

information, including the validity of 

the methodology and assumptions used 

to determine burden estimates; 

(3) ways to enhance the quality, 

utility, and clarity of the information to 

be collected; and 


ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 88, No. 219 / Wednesday, November 15, 2023 / Notices 78371 

(4) ways to minimize the burden of 

the collection of information on 

respondents, including using automated 

collection techniques when appropriate, 

and other forms of information 

technology. 

The Administration for Community 

Living (ACL) at the Department of 

Health and Human Services (HHS) is 

requesting a generic clearance for 

purposes collecting data with a focus on 

the awareness, understanding, attitudes, 

preferences, or experiences of customers 

or other stakeholders relating to existing 

or future services, products, or 

communication materials. ACL defines 

routine customer feedback as 

information that provides useful 

insights to improve existing or future 

service deliveries, products, or 

communication materials. ACL is 

requesting approval for customer 

surveys with the purpose of the 

collecting data to assist the agency in 

improving existing or future service 

deliveries, products, or communication 

materials; responses are voluntary: the 

collection does not impose a significant 

burden on respondents; the collection 

does not employ statistical methods to 

have practical utility; and the data 

results are not publicly shared. 

The types of information collection 

activities will include: 

1. Customer Comment Card/Complaint 

Form 

2. Customer Satisfaction Qualitative 

Surveys 

3. Technical Assistance 

4. Usability Testing (e.g., website or 

Software) 

5. Small Discussion Group 

6. Focus Group 

7. One-time or panel discussion groups 

8. Moderated, un-moderated, in-person, 

and/or remote-usability studies 

9. Testing of a survey or other collection 

to refine questions 

10. Post-transaction customer surveys 

11. On-line surveys 

ACL was created around the 

fundamental principle that older adults 

and people of all ages with disabilities 

should be able to live where they 

choose, with the people they choose, 

and with the ability to participate fully 

in their communities. By funding 

services and supports provided 

primarily by networks of communitybased organizations, and with 

investments in research, education, and 

innovation, ACL helps make this 

principle a reality for millions of 

Americans. Integral to this role, ACL 

will use this mechanism to conduct 

routine customer feedback for ACL 

programs. The proposed data collection 

template may be found on the ACL 

website for review at: https:// 

www.acl.gov/about-acl/public-input. 

Estimated Program Burden: ACL 

estimates the burden of this collection 

of information as follows: 

The annual burden hours (2,521) 

requested, and the anticipated number 

of respondents (10,086) are based on the 

number of potential customer feedback 

respondents. Over the course of a threeyear clearance for this generic 

information collection, ACL estimates a 

three-year burden drawdown amount of 

7,564.5 burden hours and 30,258 

respondents. 

ESTIMATED ANNUALIZED BURDEN TABLE

Type of respondent Form 

Annual 

number of 

respondents 

Number of 

responses per 

respondent 

Burden hours 

per response 

Total annual 

burden hours 

ACL Potential Customer or Stakeholder.ACL Generic Clearance for the Collection of Routine Customer 

Feedback.

10,086 1 .25 2, 521 

Dated: November 8, 2023. 

Alison Barkoff, 

Principal Deputy Administrator for the 

Administration for Community Living, 

performing the duties of the Administrator 

and the Assistant Secretary for Aging. 

[FR Doc. 2023–25129 Filed 11–14–23; 8:45 am] 

BILLING CODE 4154–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2021–N–0806] 

Advisory Committee; Nonprescription 

Drugs Advisory Committee; Renewal 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice; renewal of Federal 

advisory committee. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing the 

renewal of the Nonprescription Drugs 

Advisory Committee by the 

Commissioner of Food and Drugs (the 

Commissioner). The Commissioner has 

determined that it is in the public 

interest to renew the Nonprescription 

Drugs Advisory Committee for an 

additional 2 years beyond the charter 

expiration date. The new charter will be 

in effect until the August 27, 2025, 

expiration date. 

DATES: Authority for the 

Nonprescription Drugs Advisory 

Committee will expire on August 27, 

2025, unless the Commissioner formally 

determines that renewal is in the public 

interest. 

FOR FURTHER INFORMATION CONTACT: 

Moon Hee Choi, Center for Drug 

Evaluation and Research, Food and 

Drug Administration, 10903 New 

Hampshire Ave., Bldg. 31, Rm. 2417, 

Silver Spring, MD 20993–0002, 301– 

796–9001, NDAC@fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: Pursuant 

to 41 CFR 102–3.65 and approval by the 

Department of Health and Human 

Services and by the General Services 

Administration, FDA is announcing the 

renewal of the Nonprescription Drugs 

Advisory Committee (the Committee). 

The Committee is a discretionary 

Federal advisory committee established 

to provide advice to the Commissioner. 

The Committee advises the 

Commissioner or designee in 

discharging responsibilities as they 

relate to helping to ensure safe and 

effective drugs for human use and, as 

required, any other product for which 

FDA has regulatory responsibility. 

The Committee reviews and evaluates 

available data concerning the safety and 

effectiveness of over-the-counter 

(nonprescription) human drug products, 

or any other FDA-regulated product, for 

use in the treatment of a broad spectrum 

of human symptoms and diseases and 

advises the Commissioner either on the 

promulgation of monographs 

establishing conditions under which 

these drugs are generally recognized as 

safe and effective and not misbranded or 

on the approval of new drug 

applications for such drugs. The 

Committee serves as a forum for the 

exchange of views regarding the 

prescription and nonprescription status, 

including switches from one status to 

another, of these various drug products 

and combinations thereof. The 

Committee may also conduct peer 


ddrumheller on DSK120RN23PROD with NOTICES1